Robin M Cisco, MD
General Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cisco’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A92137 · Current
Licensed to practise in California · since 2005 · expires 2028-10-31 · Duke University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$78,105
Medicare paid this office $78,105 for 159 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal or exploration of parathyroid glands | 16 | $13,918 | $870 |
| Removal or exploration of parathyroid glands | 16 | $11,697 | $731 |
| New patient visit (60+ min) | 32 | $5,260 | $164 |
| Return visit (30+ min) | 34 | $3,930 | $98 |
| New patient visit (45+ min) | 25 | $3,050 | $122 |
See all 11 services
| Removal or exploration of parathyroid glands | 16 | $13,918 | $870 |
| Removal or exploration of parathyroid glands | 16 | $11,697 | $731 |
| New patient visit (60+ min) | 32 | $5,260 | $164 |
| Return visit (30+ min) | 34 | $3,930 | $98 |
| New patient visit (45+ min) | 25 | $3,050 | $122 |
| Long return visit (40+ min) | 15 | $2,416 | $151 |
| New patient visit (45+ min) | 17 | $1,976 | $116 |
| New patient visit (60+ min) | 13 | $1,954 | $150 |
| Return visit (30+ min) | 12 | $967 | $81 |
| Short return visit (20+ min) | 12 | $858 | $66 |
| Ultrasonic guidance during surgery | 16 | $633 | $40 |
Who their Medicare patients are
159 Original Medicare patients in 2024. Average age 73 · Women 73% · Also on Medicaid 18% · Health risk score 1.39. At or below the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: High blood pressure 74% · Diabetes 26% · Coronary heart disease 25% · Cancer 23% · Chronic kidney disease 21% · Atrial fibrillation 16% · Depression 15% · Heart failure 12% · COPD 12%.
The office billed $489,343, Medicare allowed $99,861 and paid $78,105; for 313 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 159 | 313 | 73 | 1.39 | $489,343 | $78,105 |
| 2023 | 168 | 301 | 73 | 1.31 | $334,723 | $67,057 |
| 2022 | 114 | 225 | 74 | 1.37 | $330,372 | $58,273 |
| 2021 | 115 | 254 | 73 | 1.13 | $381,578 | $72,107 |
| 2020 | 101 | 199 | 71 | 1.58 | $279,492 | $52,250 |
| 2019 | 116 | 261 | 72 | 1.53 | $342,055 | $69,930 |
| 2018 | 126 | 326 | 73 | 1.20 | $401,229 | $77,699 |
| 2017 | 94 | 266 | 72 | 1.38 | $339,484 | $58,163 |
| 2016 | 102 | 226 | 72 | 1.30 | $287,624 | $52,416 |
| 2015 | 68 | 157 | 77 | 1.38 | $99,298 | $30,906 |
| 2014 | 75 | 186 | 75 | 1.50 | $169,417 | $41,035 |
| 2013 | 68 | 183 | 75 | 1.33 | $162,785 | $38,246 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Removal or exploration of parathyroid glands | 15 | $11,117 | $741 |
| New patient visit (60+ min) | 27 | $4,023 | $149 |
| New patient visit (45+ min) | 35 | $3,805 | $109 |
| New patient visit (60+ min) | 19 | $3,173 | $167 |
| Return visit (30+ min) | 35 | $2,925 | $79 |
| Return visit (30+ min) | 21 | $2,078 | $83 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,435 | $120 |
| Short return visit (20+ min) | 19 | $1,098 | $58 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 11 | $732 | $67 |
2022: 6 services
| New patient visit (60+ min) | 19 | $3,032 | $160 |
| Return visit (30+ min) | 31 | $2,622 | $82 |
| Long return visit (40+ min) | 13 | $2,208 | $130 |
| New patient visit (45+ min) | 18 | $2,195 | $122 |
| Short return visit (20+ min) | 12 | $608 | $47 |
| Ultrasonic guidance during surgery | 11 | $594 | $54 |
2021: 9 services
| Removal or exploration of parathyroid glands | 22 | $17,462 | $794 |
| Removal of thyroid lobe on side of neck | 11 | $5,622 | $511 |
| New patient visit (60+ min) | 22 | $3,618 | $164 |
| Return visit (30+ min) | 22 | $2,266 | $87 |
| Short return visit (20+ min) | 26 | $1,623 | $54 |
| New patient visit (45+ min) | 13 | $1,517 | $117 |
| New patient visit (45+ min) | 11 | $1,390 | $126 |
| Short return visit (20+ min) | 16 | $998 | $55 |
| Ultrasonic guidance during surgery | 12 | $662 | $55 |
2020: 6 services
| Removal or exploration of parathyroid glands | 11 | $9,739 | $885 |
| Removal or exploration of parathyroid glands | 12 | $8,716 | $726 |
| New patient visit (45+ min) | 20 | $1,955 | $98 |
| New patient visit (45+ min) | 11 | $1,303 | $118 |
| Return visit (30+ min) | 18 | $1,103 | $55 |
| Short return visit (20+ min) | 23 | $1,027 | $43 |
2019: 6 services
| Removal or exploration of parathyroid glands | 17 | $13,213 | $777 |
| Removal or exploration of parathyroid glands | 11 | $8,755 | $796 |
| New patient visit (45+ min) | 32 | $3,367 | $105 |
| New patient visit (45+ min) | 28 | $3,221 | $115 |
| Return visit (30+ min) | 15 | $1,507 | $72 |
| Short return visit (20+ min) | 24 | $1,111 | $40 |
2018: 9 services
| Removal or exploration of parathyroid glands | 19 | $15,498 | $816 |
| Removal or exploration of parathyroid glands | 17 | $12,176 | $716 |
| New patient visit (45+ min) | 33 | $3,514 | $106 |
| New patient visit (45+ min) | 30 | $3,300 | $110 |
| New patient visit (60+ min) | 11 | $1,656 | $151 |
| Short return visit (20+ min) | 34 | $1,643 | $39 |
| Ultrasonic guidance during surgery | 27 | $1,458 | $54 |
| Ultrasonic guidance during surgery | 23 | $1,225 | $53 |
| Return visit (30+ min) | 14 | $1,170 | $65 |
2017: 9 services
| Removal or exploration of parathyroid glands | 12 | $9,547 | $796 |
| Removal or exploration of parathyroid glands | 12 | $9,265 | $772 |
| New patient visit (45+ min) | 32 | $3,468 | $108 |
| New patient visit (45+ min) | 16 | $1,793 | $112 |
| Return visit (30+ min) | 17 | $1,290 | $68 |
| Short return visit (20+ min) | 23 | $1,151 | $41 |
| Ultrasonic guidance during surgery | 21 | $1,099 | $52 |
| Insertion of tube into vein with collection of blood sample | 12 | $929 | $77 |
| Ultrasonic guidance during surgery | 14 | $733 | $52 |
2016: 7 services
| New patient visit (45+ min) | 30 | $3,345 | $112 |
| New patient visit (60+ min) | 14 | $1,836 | $131 |
| New patient visit (45+ min) | 13 | $1,500 | $115 |
| Return visit (30+ min) | 11 | $911 | $70 |
| Ultrasonic guidance during surgery | 14 | $755 | $54 |
| Ultrasonic guidance during surgery | 11 | $594 | $54 |
| Short return visit (20+ min) | 14 | $592 | $42 |
2015: 3 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,029 | $178 |
| New patient visit (60+ min) | 12 | $2,128 | $177 |
| Ultrasound scan of head and neck soft tissue | 11 | $1,526 | $117 |
2014: 4 services
| Removal or exploration of parathyroid glands | 11 | $8,704 | $791 |
| New patient visit (60+ min) | 24 | $4,475 | $186 |
| Ultrasound scan of head and neck soft tissue | 13 | $1,625 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,345 | $64 |
2013: 3 services
| New patient visit (60+ min) | 17 | $3,055 | $180 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,701 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,410 | $62 |
Drugs they prescribed that Part D paid
$241
Pharmacies billed $241 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
55 generic and fewer than 11 brand-name prescriptions · $241 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levothyroxine | 17 | $41 | $2 |
Year by year
| 2024 | 61 | 32 | None | None | $241 |
| 2023 | 60 | 36 | None | None | $1,437 |
| 2022 | 18 | 12 | None | 0% | $202 |
| 2021 | 29 | 17 | None | None | $423 |
| 2020 | 36 | 13 | 0% (0) | 33% | $626 |
| 2019 | 52 | 18 | None | 35% | $589 |
| 2018 | 90 | 46 | 17% (15) | 23% | $1,197 |
| 2017 | 66 | 27 | 20% (13) | None | $1,737 |
| 2016 | 56 | 26 | 20% (11) | 32% | $1,153 |
| 2015 | 53 | 23 | 34% (18) | None | $1,512 |
| 2014 | 50 | 22 | 32% (16) | None | $527 |
| 2013 | 24 | 12 | None | None | $285 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Levothyroxine | 13 | $89 | $7 |
2020: 1 drug
| Levothyroxine | 17 | $223 | $13 |
2019: 1 drug
| Levothyroxine | 35 | $391 | $11 |
2018: 3 drugs
| Levothyroxine | 34 | $528 | $16 |
| Calcitriol | 16 | $303 | $19 |
| Hydrocodone-Acetaminophen | 15 | $61 | $4 |
2017: 3 drugs
| Calcitriol | 24 | $822 | $34 |
| Levothyroxine | 19 | $409 | $22 |
| Hydrocodone-Acetaminophen | 11 | $62 | $6 |
2016: 2 drugs
| Levothyroxine | 26 | $337 | $13 |
| Calcitriol | 13 | $256 | $20 |
2015: 1 drug
| Levothyroxine | 18 | $301 | $17 |
2014: 2 drugs
| Levothyroxine | 23 | $175 | $8 |
| Hydrocodone-Acetaminophen | 16 | $123 | $8 |
Money from drug and device companies
$28 in 2025
A payment is not proof that care is biased.
| Ethicon US | Echelon Flex | $28 | 2 payments
|
See all 2 published payments
| Ethicon US | Meals · 2025-12-09 | Echelon Circular | $14 |
| Ethicon US | Meals · 2025-03-04 | Echelon Flex | $14 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093973729
- Licence
- CA A92137California A92137: Current · expires 2028-10-31
- Trained
- Duke University School of Medicine, 2004
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2008-05-29
- NPI last updated
- 2024-04-28
- NPI record certified
- 2024-04-28
This is when the NPI record was last certified, not a medical board exam.